Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02628847 · ClinicalTrials.gov registry record · Phase 1
Sildenafil and Stroke Recovery
A Phase 1 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT02628847 is a Phase 1 study that was terminated before completion, run by University of Utah. The registered enrollment target is 11 participants.
The verdict
NCT02628847, a Phase 1 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
This is a small, pilot randomized clinical trial of administering sildenafil citrate to individuals within 10 days of ischemic stroke who have motor impairment and who are undergoing inpatient rehabilitation compared to placebo. The primary outcome is motor recovery at one and three months.
Interventions
- DRUG Placebo
- DRUG sildenafil citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2012-03 |
| Est. Completion | 2016-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02628847
The ClinicalTrials.gov registry entry for NCT02628847 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02628847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02628847 about?
NCT02628847 is a clinical study titled "Sildenafil and Stroke Recovery". This is a small, pilot randomized clinical trial of administering sildenafil citrate to individuals within 10 days of ischemic stroke who have motor impairment and who are undergoing inpatient rehabilitation compared to placebo. The primary outcome is motor recovery at one and three months.
What is the current status of trial NCT02628847?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2012-03. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02628847?
The interventions under investigation include: Placebo (DRUG), sildenafil citrate (DRUG).
Who is sponsoring clinical trial NCT02628847?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.